265 related articles for article (PubMed ID: 33308444)
1. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.
Lin YC; Niceta M; Muto V; Vona B; Pagnamenta AT; Maroofian R; Beetz C; van Duyvenvoorde H; Dentici ML; Lauffer P; Vallian S; Ciolfi A; Pizzi S; Bauer P; Grüning NM; Bellacchio E; Del Fattore A; Petrini S; Shaheen R; Tiosano D; Halloun R; Pode-Shakked B; Albayrak HM; Işık E; Wit JM; Dittrich M; Freire BL; Bertola DR; Jorge AAL; Barel O; Sabir AH; Al Tenaiji AMJ; Taji SM; Al-Sannaa N; Al-Abdulwahed H; Digilio MC; Irving M; Anikster Y; Bhavani GSL; Girisha KM; ; Haaf T; Taylor JC; Dallapiccola B; Alkuraya FS; Yang RB; Tartaglia M
Am J Hum Genet; 2021 Jan; 108(1):115-133. PubMed ID: 33308444
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
3. SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development.
Tu CF; Tsao KC; Lee SJ; Yang RB
J Biol Chem; 2014 Jul; 289(27):18928-42. PubMed ID: 24849601
[TBL] [Abstract][Full Text] [Related]
4. Altered plasma membrane dynamics of bone morphogenetic protein receptor type Ia in a low bone mass mouse model.
Bragdon B; D'Angelo A; Gurski L; Bonor J; Schultz KL; Beamer WG; Rosen CJ; Nohe A
Bone; 2012 Jan; 50(1):189-99. PubMed ID: 22036911
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein receptor type Ia localization causes increased BMP2 signaling in mice exhibiting increased peak bone mass phenotype.
Bragdon B; Bonor J; Shultz KL; Beamer WG; Rosen CJ; Nohe A
J Cell Physiol; 2012 Jul; 227(7):2870-9. PubMed ID: 22170575
[TBL] [Abstract][Full Text] [Related]
6. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
[TBL] [Abstract][Full Text] [Related]
7. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.
Boström KI; Jumabay M; Matveyenko A; Nicholas SB; Yao Y
Circ Res; 2011 Feb; 108(4):446-57. PubMed ID: 21193740
[TBL] [Abstract][Full Text] [Related]
8. BMP signaling in skeletal development.
Wan M; Cao X
Biochem Biophys Res Commun; 2005 Mar; 328(3):651-7. PubMed ID: 15694398
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
Nifuji A; Miura N; Kato N; Kellermann O; Noda M
J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
[TBL] [Abstract][Full Text] [Related]
10. Sprouty2 regulates endochondral bone formation by modulation of RTK and BMP signaling.
Joo A; Long R; Cheng Z; Alexander C; Chang W; Klein OD
Bone; 2016 Jul; 88():170-179. PubMed ID: 27130872
[TBL] [Abstract][Full Text] [Related]
11. Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.
Church RH; Krishnakumar A; Urbanek A; Geschwindner S; Meneely J; Bianchi A; Basta B; Monaghan S; Elliot C; Strömstedt M; Ferguson N; Martin F; Brazil DP
Biochem J; 2015 Feb; 466(1):55-68. PubMed ID: 25378054
[TBL] [Abstract][Full Text] [Related]
12. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
13. Dkk1 haploinsufficiency requires expression of Bmp2 for bone anabolic activity.
Intini G; Nyman JS
Bone; 2015 Jun; 75():151-60. PubMed ID: 25603465
[TBL] [Abstract][Full Text] [Related]
14. Bmp signaling regulates a dose-dependent transcriptional program to control facial skeletal development.
Bonilla-Claudio M; Wang J; Bai Y; Klysik E; Selever J; Martin JF
Development; 2012 Feb; 139(4):709-19. PubMed ID: 22219353
[TBL] [Abstract][Full Text] [Related]
15. SCUBE1-enhanced bone morphogenetic protein signaling protects against renal ischemia-reperfusion injury.
Liao WJ; Lin H; Cheng CF; Ka SM; Chen A; Yang RB
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):329-338. PubMed ID: 30414502
[TBL] [Abstract][Full Text] [Related]
16. BMP signalling in skeletal development, disease and repair.
Salazar VS; Gamer LW; Rosen V
Nat Rev Endocrinol; 2016 Apr; 12(4):203-21. PubMed ID: 26893264
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
19. ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K/AKT pathway.
Ayala-Peña VB; Scolaro LA; Santillán GE
Exp Cell Res; 2013 Aug; 319(13):2028-2036. PubMed ID: 23707969
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.
Mundy C; Yang E; Takano H; Billings PC; Pacifici M
J Biol Chem; 2018 May; 293(20):7703-7716. PubMed ID: 29622677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
